Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects

NCT02264197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBX 245 CL - fed
DRUG: BIBX 245 CL- fasted

Sponsor

Boehringer Ingelheim